- Home
- PYXS vs HYFT Comparison
PYXS vs HYFT Comparison
Compare PYXS & HYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYXS
- HYFT
- Stock Information
- Founded
- PYXS 2018
- HYFT 1983
- Country
- PYXS United States
- HYFT United States
- Employees
- PYXS N/A
- HYFT N/A
- Industry
- PYXS Biotechnology: Pharmaceutical Preparations
- HYFT Biotechnology: Pharmaceutical Preparations
- Sector
- PYXS Health Care
- HYFT Health Care
- Exchange
- PYXS Nasdaq
- HYFT Nasdaq
- Market Cap
- PYXS 79.4M
- HYFT 80.8M
- IPO Year
- PYXS 2021
- HYFT 2017
- Fundamental
- Price
- PYXS $3.48
- HYFT $1.67
- Analyst Decision
- PYXS Strong Buy
- HYFT
- Analyst Count
- PYXS 5
- HYFT 0
- Target Price
- PYXS $7.75
- HYFT N/A
- AVG Volume (30 Days)
- PYXS 877.2K
- HYFT 600.8K
- Earning Date
- PYXS 11-11-2025
- HYFT 12-09-2025
- Dividend Yield
- PYXS N/A
- HYFT N/A
- EPS Growth
- PYXS N/A
- HYFT N/A
- EPS
- PYXS N/A
- HYFT N/A
- Revenue
- PYXS $2,820,000.00
- HYFT $18,214,531.00
- Revenue This Year
- PYXS N/A
- HYFT N/A
- Revenue Next Year
- PYXS N/A
- HYFT $71.78
- P/E Ratio
- PYXS N/A
- HYFT N/A
- Revenue Growth
- PYXS N/A
- HYFT 18.33
- 52 Week Low
- PYXS $0.83
- HYFT $0.27
- 52 Week High
- PYXS $5.39
- HYFT $3.25
- Technical
- Relative Strength Index (RSI)
- PYXS 60.49
- HYFT N/A
- Support Level
- PYXS $3.17
- HYFT N/A
- Resistance Level
- PYXS $3.75
- HYFT N/A
- Average True Range (ATR)
- PYXS 0.31
- HYFT 0.00
- MACD
- PYXS -0.05
- HYFT 0.00
- Stochastic Oscillator
- PYXS 33.62
- HYFT 0.00
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.
About HYFT MindWalk Holdings Corp. Common Stock
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.